24-week, Post-Marketing Surveillance Analysis of Upadacitinib in Japanese Patients with Rheumatoid Arthritis: The 2024 Interim Report

被引：0
|
作者：
Fujii, Takao [1 ]
Okamoto, Nami [2 ]
Abe, Asami [3 ]
Takagi, Michiaki [4 ]
Takahashi, Nobunori [5 ]
Nakajima, Atsuo [6 ]
Nakajima, Ayako [7 ]
Nakayamada, Shingo [8 ]
Nishida, Keiichiro [9 ]
Kawaberi, Takeshi [10 ]
Sunaga, Naomi [10 ]
Tsujita, Yuki [11 ]
Chonan, Sumi [12 ]
Kuwana, Masataka [13 ]
Tanaka, Yoshiya [14 ]
机构：
[1] Wakayama Med Univ, Wakayama, Japan
[2] Osaka Rosai Hosp, Sakai, Osaka, Japan
[3] Niigata Rheumat Ctr, Shibata, Japan
[4] Yamagata Univ, Fac Med, Yamagata, Japan
[5] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan
[6] Ueno Dialysis Clin, Tokyo, Japan
[7] Mie Univ Hosp, Ctr Rheumat Dis, Tsu, Mie, Japan
[8] Univ Occupat & Environm Hlth Japan, Dept Internal Med 1, Kitakyushu, Fukuoka, Japan
[9] Okayama Univ, Dept Orthoped Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[10] Abbvie GK, Minato Ku, Tokyo, Japan
[11] AbbVie, Minato, Tokyo, Japan
[12] Abbvie GK, Tokyo, Japan
[13] Nippon Med Sch, Dept Allergy & Rheumatol, Tokyo, Japan
[14] Univ Occupat & Environm Hlth, Dept Internal Med, Kitakyushu, Fukuoka, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0506
引用
收藏
页码：1026 / 1029
页数：4
相关论文
共 50 条
  • [21] Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
    Hirohito Shimizu
    Hisanori Kobayashi
    Masayoshi Kanbori
    Yutaka Ishii
    Rheumatology and Therapy, 2020, 7 : 1053 - 1053
  • [22] Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance
    Murai, Hiroyuki
    Suzuki, Shigeaki
    Hasebe, Miki
    Fukamizu, Yuji
    Rodrigues, Ema
    Utsugisawa, Kimiaki
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [23] INTERIM REPORT OF A POST-MARKETING SURVEILLANCE OF PALIPERIDONE PALMITATE 3-MONTH FORMULATION IN JAPANESE PATIENTS WITH SCHIZOPHRENIA
    Marumoto, Tatsuro
    Saga, Yosuke
    Kinoshita, Hiroaki
    Morita, Natsuko
    Touma, Tokiko
    Wakamatsu, Shinya
    Takebe, Kyoko
    Wakamatsu, Akihide
    Chiang, Chih-Lin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i160 - i160
  • [24] Effectiveness of Upadacitinib in Patients with Rheumatoid Arthritis in German Real-World Practice: Interim Results from a Post-Marketing Observational Study
    Witte, Torsten
    Kiltz, Uta
    Haas, Florian
    Riechers, Elke
    Prothmann, Ulrich
    Adolf, Daniela
    Holland, Carsten
    Hecht, Rouven
    Roessler, Alexander
    Famulla, Kirsten
    Goetz, Konrad
    Krueger, Klaus
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1720 - 1723
  • [25] Safety and effectiveness of denosumab in Japanese patients with rheumatoid arthritis: A 2-year post-marketing surveillance study
    Tanaka, Yoshiya
    Mizutani, Hideki
    Fujii, Kunimitsu
    Okubo, Naoki
    MODERN RHEUMATOLOGY, 2023, 34 (05) : 927 - 935
  • [26] Safety and Efficacy of Fingolimod in Japanese Patients with Multiple Sclerosis: Interim Analysis Results from Post-marketing Surveillance
    Kira, J.
    Fujihara, K.
    Ueda, K.
    Tajima, T.
    Ueno, M.
    Saida, T.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 928 - 928
  • [27] Safety of crizotinib in 892 Japanese ALK-positive advanced NSCLC patients: Interim report of post-marketing surveillance
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    Ohe, Yuichiro
    Ueno, Naomi
    Banno, Shigeo
    Endo, Yutaka
    Ohki, Emiko
    Gemma, Akihiko
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 37
  • [28] Safety and Effectiveness Of Abatacept In 3985 Japanese Patients With Rheumatoid Arthritis; Japan All-Cases Post-Marketing Surveillance
    Koike, Takao
    Harigai, Masayoshi
    Ishiguro, Naoki
    Inokuma, Shigeko
    Ryu, Junnosuke
    Takei, Syuji
    Takeuchi, Tsutomu
    Tanaka, Y.
    Watanabe, Masahiko
    Yamanaka, Hisashi
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S598 - S598
  • [29] POST-MARKETING SAFETY SURVEILLANCE OF TOFACITINIB OVER 9 YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS
    Burmester, G. R.
    Coates, L.
    Cohen, S. B.
    Tanaka, Y.
    Vranic, I.
    Nagy, E.
    Chen, A. S.
    Lazariciu, I.
    Kwok, K.
    Fallon, L.
    Kinch, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 347 - 348
  • [30] Post-marketing surveillance of high-dose methotrexate (>8 mg/week) in Japanese patients with rheumatoid arthritis: A post hoc sub-analysis of patients according to duration of prior methotrexate use
    Suzuki, Yasuo
    Hirose, Tomohiro
    Sugiyama, Noriko
    Nomura, Kazuto
    Campos-Alberto, Eduardo
    MODERN RHEUMATOLOGY, 2021, 31 (03) : 575 - 586
12345